Brexit and Its Impact on Pharmaceutical Law: Implications for Global Pharma Companies
Crossref DOI link: https://doi.org/10.1007/978-3-030-35918-8_4
Published Online: 2020-02-20
Published Print: 2020
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Heusler, Johannes
Funding for this research was provided by:
Goethe Business School GmbH, Frankfurt/Main, Germany
Text and Data Mining valid from 2020-01-01
Version of Record valid from 2020-02-20
Chapter History
First Online: 20 February 2020